Paraphilic DisordersNCT05628402
Exhibitionnists's Cognitive Mecanisms
An observational study of Paraphilic Disorders and Exhibitionism, run by University Hospital, Montpellier at 1 site in France.
Trial summary
Exhibitionism is a paraphilia, which is defined according to the DSM 5. The estimated prevalence in men is between 2 to 4% (The prevalence of exhibitionistic disorder in females is even more uncertain but is generally believed to be much lower than in males). Read more about this study
- Who is it for?
- Ages 18 years and older, men only
- Conditions the study is for
- Paraphilic Disorders, Exhibitionism
- What is being tested?
- Semi-structured interview
- How many people
- 20 participants
- Where
- 1 siteFrance
- Study dates
- 6 Sep 2022to 1 Jul 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- No healthy volunteers
- Adult, Older adult
Study population: Men followed for exhibitionism
Who may be able to join
- male > 18 years
- followed in Resource Centre for Interveners with Perpetrators of Sexual Violence of Montpellier UH
- exhibitionnists
- agree to participate
Who cannot join
- dementia
- severe intellectual desability
- decompensated psychiatric didease
Trial locations and contacts
1 site in 1 country.
France1 site, 1 recruiting
- Recruiting
CHU Montpellier : Lapeyronie CRIAVS
Montpellier, 34295
Céline BAIS, MD, +33467338677, c-bais@chu-montpellier.fr
About this study
Official title: Qualitative Study on Cognitive Mecanisms Involved in Exhibitionists's Acting Out
Exhibitionism is a paraphilia, which is defined according to the DSM 5. The estimated prevalence in men is between 2 to 4% (The prevalence of exhibitionistic disorder in females is even more uncertain but is generally believed to be much lower than in males).
At judiciary level: approximately 30% of apprehended male sex offenders are exhibitionists. They have the highest recidivism rate of any sex offender; about 20-50% are arrested again.
The studies are old and not very prolific on the subject of exhibition. The available data are lacking, there is no clinical evaluation scale for exhibitionism. The diagnosis is essentially based on facts with judicial characteristics "did patient show himself? ", "Does he enjoy showing off?". Investigators have no data on the cognitive distortions that support this particular acting out, the (specific) triggering factors and the potential psychological vulnerabilities of exhibitionists Some cognitive and sensory mechanisms may be involved in the origin and development of the processes underlying the act (Johnston and Ward 1996). The investigators will rely on the identification of anticipatory, relieving and permissive beliefs as a schema that can explain cognitive processes leading to acting out (Johnston and Ward, 1996). The goal is to apply this approach to exhibitionism. It should be noted that this model of thoughts (anticipatory, relieving and permissive) is taken up in the field of addiction. Exhibition is generally presented in the literature as a possible addictive disorder (Jon E. et al). The investigators will investigate whether there are specific factors precipitating exhibitionnism's acting out, other than the general precipitating factors or the recidivism risk factors known in sexual violence (SONAR, STATIC-99, PCL- R, SVR-20…). The investigators will also study the psychological vulnerabilies of these subjects.
- Conditions
- Paraphilic Disorders, Exhibitionism
- Being tested
- Semi-structured interview
- Keywords
- sex offender, sexual violence, acting out
- Medical subject headings
- Paraphilic Disorders, Exhibitionism
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Semi-structured interviewOther
The semi-structured interview will take place during a standard follow-up appointment with the therapist already treating the patient after the patient has agreed to participate in the study.
| Study group | Role | What they receive |
|---|---|---|
| exhibitionist patients | Not described Receives: Other: Semi-structured interview |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-questionnaire
collective and personal representation on the phenomeon, self-reflexivity in relation to personality, self reflexivity in relation to body and sexuality, exploration of the lived expérience of exhbition, exploration of evolution in term of addiction
Measured: Day 1 (inclusion)
Secondary outcomes (1)
Sexual Addiction Screening Test : SAST-Fr
The Sexual Addiction Screening Test (SAST) is designed to assist in the assessment of sexually compulsive or "addictive" behavior.
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Nov 2022
- Study start6 Sep 2022
- Primary completion1 Apr 2023 (estimated)
- Study completion1 Jul 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Paraphilic DisordersStudies of the same condition, open and under way.
- More trials run by University Hospital, MontpellierThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Montpellier
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05628402
- Sponsor's protocol ID
- RECHMPL22_0411
- Status last verified
- Nov 2022
- First submitted
- 16 Nov 2022
- Last updated
- 1 Dec 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Marais C, Song Y, Ferreira R, Aounti S, Duflos C, Baptista G, Pers YM. Evaluation of mindfulness based stress reduction in symptomatic knee or hip osteoarthritis patients: a pilot randomized controlled trial. BMC Rheumatol. 2022 May 30;6(1):46. doi: 10.1186/s41927-022-00277-9.
PubMed 35637515
Study at a glance
From the registry record, last updated by the sponsor on 1 Dec 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Qualitative Study on Cognitive Mecanisms Involved in Exhibitionists's Acting Out
- ClinicalTrials.gov ID
- NCT05628402
- Acronym / sponsor ID
- RECHMPL22_0411
- Conditions
- Paraphilic Disorders, Exhibitionism
- Keywords
- sex offender, sexual violence, acting out
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- University Hospital, MontpellierUniversity, hospital or other
- Study start
- 6 Sep 2022 (actual)
- Primary completion
- 1 Apr 2023 (estimated)
- Study completion
- 1 Jul 2023 (estimated)
- First posted
- 28 Nov 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Exhibitionism is a paraphilia, which is defined according to the DSM 5. The estimated prevalence in men is between 2 to 4% (The prevalence of exhibitionistic disorder in females is even more uncertain but is generally believed to be much lower than in males).
At judiciary level: approximately 30% of apprehended male sex offenders are exhibitionists. They have the highest recidivism rate of any sex offender; about 20-50% are arrested again.
The studies are old and not very prolific on the subject of exhibition. The available data are lacking, there is no clinical evaluation scale for exhibitionism. The diagnosis is essentially based on facts with judicial characteristics "did patient show himself? ", "Does he enjoy showing off?". Investigators have no data on the cognitive distortions that support this particular acting out, the (specific) triggering factors and the potential psychological vulnerabilities of exhibitionists Some cognitive and sensory mechanisms may be involved in the origin and development of the processes underlying the act (Johnston and Ward 1996). The investigators will rely on the identification of anticipatory, relieving and permissive beliefs as a schema that can explain cognitive processes leading to acting out (Johnston and Ward, 1996). The goal is to apply this approach to exhibitionism. It should be noted that this model of thoughts (anticipatory, relieving and permissive) is taken up in the field of addiction. Exhibition is generally presented in the literature as a possible addictive disorder (Jon E. et al). The investigators will investigate whether there are specific factors precipitating exhibitionnism's acting out, other than the general precipitating factors or the recidivism risk factors known in sexual violence (SONAR, STATIC-99, PCL- R, SVR-20…). The investigators will also study the psychological vulnerabilies of these subjects.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| exhibitionist patients | – | Other: Semi-structured interview |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Men followed for exhibitionism
Key inclusion criteria (4 listed)
- male > 18 years
- followed in Resource Centre for Interveners with Perpetrators of Sexual Violence of Montpellier UH
- exhibitionnists
- agree to participate
Key exclusion criteria (3 listed)
- dementia
- severe intellectual desability
- decompensated psychiatric didease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Semi-structured interviewThe semi-structured interview will take place during a standard follow-up appointment with the therapist already treating the patient after the patient has agreed to participate in the study. | Other | exhibitionist patients |
Primary outcome
Self-questionnaire
Time frame: Day 1 (inclusion)
collective and personal representation on the phenomeon, self-reflexivity in relation to personality, self reflexivity in relation to body and sexuality, exploration of the lived expérience of exhbition, exploration of evolution in term of addiction
1 secondary outcome
Sexual Addiction Screening Test : SAST-Fr
Time frame: Day 1
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Dec 2022.
- Results publication: PubMed 35637515Marais C, Song Y, Ferreira R, Aounti S, Duflos C, Baptista G, Pers YM. Evaluation of mindfulness based stress reduction in symptomatic knee or hip osteoarthritis patients: a pilot randomized controlled trial. BMC Rheumatol. 2022 May 30;6(1):46. doi: 10.1186/s41927-022-00277-9.
- open accessLink provided by the sponsor.
Related trials for Paraphilic Disorders
Recruiting
A Group Based Psychoeducational Intervention for Partners of Child Sexual Abuse Material Offenders.
Partner
RecruitingObservational study
Paraphilic Disorders and Other Conditions With Risk for Sexual Violence: a Case-control Study
Paraphilic Disorders, Sexual Addiction
Recruiting
Psychological Treatment for Paraphilic Disorders
Paraphilic Disorders
Not yet recruitingObservational study
"Evolution of Sexual Symptoms in Paraphilic Sexual Offenders With/Without Antiandrogen or SSRI Treatment"
Sexual Disorder, Physiological
Recruiting
Talking for Change: Secondary Prevention of Child Sexual Abuse Perpetration
Pedophilia, Hebephilia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Paraphilic Disorders and Exhibitionism, run by University Hospital, Montpellier at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 1 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Magali TEILLARD (+33 467338577, m-teillard_dirat@chu-montpellier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-questionnaire (time frame: Day 1 (inclusion)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05628402, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Dec 2022.